Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse.
Abstract
No abstract available.
Authors
- Boutros PC
- Bristow RG
- Finelli A
- Fraser M
- He HH
- Livingstone J
- Wrana JL
- Zlotta AR
- van der Kwast T